[10-Q] NORDSON CORP Quarterly Earnings Report

Rhea-AI Filing Summary

Nordson Corporation reported strong quarterly growth. For the three months ended January 31, 2026, sales rose 8.8% to $669,461 thousand, driven by demand in Industrial Precision Solutions and a 23.2% organic increase in Asia Pacific sales.

Net income increased 40.9% to $133,382 thousand, and diluted earnings per share grew to $2.38 from $1.65, helped by higher operating profit, lower interest expense and an unrealized gain of $22,238 thousand on a minority investment. Gross margin edged up to 54.7%, while segment EBITDA improved in Medical and Fluid Solutions and Advanced Technology Solutions.

Operating cash flow was $140,428 thousand, supporting $86,001 thousand of share repurchases and $45,786 thousand of dividends. The company ended the quarter with cash of $120,392 thousand and $2,004,312 thousand of gross long-term debt, including $400,000 thousand drawn on a new $1,200,000 thousand revolving credit facility maturing in 2031.

Insights

Equity analyst

Nordson posts strong EPS growth, aided by one-time investment gains.

Nordson delivered top-line growth of 8.8% to $669,461 thousand and expanded operating profit to $166,405 thousand. The mix of steady gross margin at 54.7% and tighter selling and administrative expenses supported higher profitability.

Net income climbed to $133,382 thousand, but part of the jump reflects a $22,238 thousand unrealized gain on a minority investment now carried at fair value. Segment EBITDA margin improved notably in Medical and Fluid Solutions and Advanced Technology Solutions, offsetting a margin decline in Industrial Precision Solutions.

Investors may focus on the sustainability of earnings once the investment gain is excluded and on continued momentum in Asia Pacific, where organic sales rose 23.2%. Future filings for periods ending after January 31, 2026 will clarify whether these trends persist.

Credit analyst

Leverage remains manageable as Nordson refinances and returns cash.

The company ended the quarter with gross long-term debt of $2,004,312 thousand and cash of $120,392 thousand. It replaced a prior facility with a new $1,200,000 thousand unsecured multicurrency revolver maturing in 2031, with $400,000 thousand drawn at a weighted rate of 4.69%.

Cash from operations of $140,428 thousand funded $17,513 thousand of capital spending, $45,786 thousand in dividends and $86,001 thousand of share repurchases, while net debt changed modestly. Covenants were in compliance, and available borrowing capacity plus strong operating cash flows support liquidity for upcoming maturities through 2033.

Subsequent periods will show how the new revolver and ongoing share repurchases affect leverage metrics, especially as interest expense was already reduced to $23,131 thousand in the quarter compared with the prior year.

false2026Q10000072331October 31xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purendsn:segment00000723312025-11-012026-01-3100000723312026-02-1800000723312024-11-012025-01-3100000723312026-01-3100000723312025-10-310000072331us-gaap:CommonStockMember2025-10-310000072331us-gaap:AdditionalPaidInCapitalMember2025-10-310000072331us-gaap:RetainedEarningsMember2025-10-310000072331us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-10-310000072331us-gaap:TreasuryStockCommonMember2025-10-310000072331us-gaap:AdditionalPaidInCapitalMember2025-11-012026-01-310000072331us-gaap:TreasuryStockCommonMember2025-11-012026-01-310000072331us-gaap:RetainedEarningsMember2025-11-012026-01-310000072331us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-11-012026-01-310000072331us-gaap:CommonStockMember2026-01-310000072331us-gaap:AdditionalPaidInCapitalMember2026-01-310000072331us-gaap:RetainedEarningsMember2026-01-310000072331us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-310000072331us-gaap:TreasuryStockCommonMember2026-01-310000072331us-gaap:CommonStockMember2024-10-310000072331us-gaap:AdditionalPaidInCapitalMember2024-10-310000072331us-gaap:RetainedEarningsMember2024-10-310000072331us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-310000072331us-gaap:TreasuryStockCommonMember2024-10-3100000723312024-10-310000072331us-gaap:AdditionalPaidInCapitalMember2024-11-012025-01-310000072331us-gaap:TreasuryStockCommonMember2024-11-012025-01-310000072331us-gaap:RetainedEarningsMember2024-11-012025-01-310000072331us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-11-012025-01-310000072331us-gaap:CommonStockMember2025-01-310000072331us-gaap:AdditionalPaidInCapitalMember2025-01-310000072331us-gaap:RetainedEarningsMember2025-01-310000072331us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-310000072331us-gaap:TreasuryStockCommonMember2025-01-3100000723312025-01-310000072331us-gaap:EmployeeStockOptionMember2025-11-012026-01-310000072331us-gaap:EmployeeStockOptionMember2024-11-012025-01-310000072331us-gaap:LandMember2026-01-310000072331us-gaap:LandMember2025-10-310000072331us-gaap:LandImprovementsMember2026-01-310000072331us-gaap:LandImprovementsMember2025-10-310000072331us-gaap:BuildingMember2026-01-310000072331us-gaap:BuildingMember2025-10-310000072331us-gaap:MachineryAndEquipmentMember2026-01-310000072331us-gaap:MachineryAndEquipmentMember2025-10-310000072331ndsn:EnterpriseManagementSystemsMember2026-01-310000072331ndsn:EnterpriseManagementSystemsMember2025-10-310000072331us-gaap:ConstructionInProgressMember2026-01-310000072331us-gaap:ConstructionInProgressMember2025-10-310000072331us-gaap:LeaseholdsAndLeaseholdImprovementsMember2026-01-310000072331us-gaap:LeaseholdsAndLeaseholdImprovementsMember2025-10-310000072331ndsn:IndustrialPrecisionSolutionsMember2025-10-310000072331ndsn:MedicalFluidSystemsMember2025-10-310000072331ndsn:AdvancedTechnologySolutionsMember2025-10-310000072331ndsn:IndustrialPrecisionSolutionsMember2025-11-012026-01-310000072331ndsn:MedicalFluidSystemsMember2025-11-012026-01-310000072331ndsn:AdvancedTechnologySolutionsMember2025-11-012026-01-310000072331ndsn:IndustrialPrecisionSolutionsMember2026-01-310000072331ndsn:MedicalFluidSystemsMember2026-01-310000072331ndsn:AdvancedTechnologySolutionsMember2026-01-310000072331us-gaap:CustomerRelationshipsMember2026-01-310000072331us-gaap:PatentedTechnologyMember2026-01-310000072331us-gaap:TradeNamesMember2026-01-310000072331us-gaap:NoncompeteAgreementsMember2026-01-310000072331us-gaap:OtherIntangibleAssetsMember2026-01-310000072331us-gaap:CustomerRelationshipsMember2025-10-310000072331us-gaap:PatentedTechnologyMember2025-10-310000072331us-gaap:TradeNamesMember2025-10-310000072331us-gaap:NoncompeteAgreementsMember2025-10-310000072331us-gaap:OtherIntangibleAssetsMember2025-10-310000072331country:USus-gaap:PensionPlansDefinedBenefitMember2025-11-012026-01-310000072331country:USus-gaap:PensionPlansDefinedBenefitMember2024-11-012025-01-310000072331us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2025-11-012026-01-310000072331us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-11-012025-01-310000072331country:USus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-11-012026-01-310000072331country:USus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-11-012025-01-310000072331us-gaap:AccumulatedTranslationAdjustmentMember2025-10-310000072331us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-10-310000072331us-gaap:AccumulatedTranslationAdjustmentMember2025-11-012026-01-310000072331us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-11-012026-01-310000072331us-gaap:AccumulatedTranslationAdjustmentMember2026-01-310000072331us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-01-310000072331us-gaap:OperatingSegmentsMemberndsn:IndustrialPrecisionsSolutionsMember2025-11-012026-01-310000072331us-gaap:OperatingSegmentsMemberndsn:IndustrialPrecisionsSolutionsMember2024-11-012025-01-310000072331us-gaap:OperatingSegmentsMemberndsn:MedicalFluidSystemsMember2025-11-012026-01-310000072331us-gaap:OperatingSegmentsMemberndsn:MedicalFluidSystemsMember2024-11-012025-01-310000072331us-gaap:OperatingSegmentsMemberndsn:AdvancedTechnologySystemsMember2025-11-012026-01-310000072331us-gaap:OperatingSegmentsMemberndsn:AdvancedTechnologySystemsMember2024-11-012025-01-310000072331us-gaap:CorporateNonSegmentMember2025-11-012026-01-310000072331us-gaap:OperatingSegmentsMemberndsn:IndustrialPrecisionsSolutionsMember2026-01-310000072331us-gaap:OperatingSegmentsMemberndsn:MedicalFluidSystemsMember2026-01-310000072331us-gaap:OperatingSegmentsMemberndsn:AdvancedTechnologySystemsMember2026-01-310000072331us-gaap:CorporateNonSegmentMember2026-01-310000072331us-gaap:CorporateNonSegmentMember2024-11-012025-01-310000072331us-gaap:OperatingSegmentsMemberndsn:IndustrialPrecisionsSolutionsMember2025-01-310000072331us-gaap:OperatingSegmentsMemberndsn:MedicalFluidSystemsMember2025-01-310000072331us-gaap:OperatingSegmentsMemberndsn:AdvancedTechnologySystemsMember2025-01-310000072331us-gaap:CorporateNonSegmentMember2025-01-310000072331ndsn:AmericasExcludingUnitedStatesMember2025-11-012026-01-310000072331ndsn:AmericasExcludingUnitedStatesMember2024-11-012025-01-310000072331srt:EuropeMember2025-11-012026-01-310000072331srt:EuropeMember2024-11-012025-01-310000072331ndsn:AsiaPacificExcludingJapanMember2025-11-012026-01-310000072331ndsn:AsiaPacificExcludingJapanMember2024-11-012025-01-310000072331srt:AmericasMember2026-01-310000072331srt:AmericasMember2025-01-310000072331srt:EuropeMember2026-01-310000072331srt:EuropeMember2025-01-310000072331ndsn:AsiaPacificExcludingJapanMember2026-01-310000072331ndsn:AsiaPacificExcludingJapanMember2025-01-310000072331country:US2025-11-012026-01-310000072331country:US2024-11-012025-01-310000072331country:US2026-01-310000072331country:US2025-01-310000072331us-gaap:FairValueInputsLevel2Member2026-01-310000072331us-gaap:FairValueMeasurementsRecurringMember2026-01-310000072331us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2026-01-310000072331us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2026-01-310000072331us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2026-01-310000072331us-gaap:FairValueInputsLevel2Member2025-10-310000072331us-gaap:FairValueMeasurementsRecurringMember2025-10-310000072331us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-10-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-01-310000072331us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-01-310000072331us-gaap:InterestRateSwapMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-01-310000072331us-gaap:InterestRateSwapMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2026-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2026-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2026-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMember2026-01-310000072331us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2026-01-310000072331us-gaap:OtherAssetsMember2026-01-310000072331us-gaap:AccruedLiabilitiesMember2026-01-310000072331us-gaap:OtherNoncurrentLiabilitiesMember2026-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-01-310000072331us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-01-310000072331us-gaap:InterestRateSwapMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-01-310000072331us-gaap:InterestRateSwapMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2025-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMember2025-01-310000072331us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2025-01-310000072331us-gaap:OtherAssetsMember2025-01-310000072331us-gaap:AccruedLiabilitiesMember2025-01-310000072331us-gaap:OtherNoncurrentLiabilitiesMember2025-01-310000072331us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2025-11-012026-01-310000072331us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2024-11-012025-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2025-11-012026-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2024-11-012025-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2025-11-012026-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2024-11-012025-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberndsn:CumulativeTranslationMember2025-11-012026-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberndsn:CumulativeTranslationMember2024-11-012025-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-11-012026-01-310000072331us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-11-012025-01-310000072331ndsn:RevolvingCreditAgreementDue2031Member2026-01-310000072331ndsn:RevolvingCreditAgreementDue2031Member2025-10-310000072331ndsn:RevolvingCreditAgreementDue2028Member2026-01-310000072331ndsn:RevolvingCreditAgreementDue2028Member2025-10-310000072331ndsn:TermLoanDue2026Member2026-01-310000072331ndsn:TermLoanDue2026Member2025-10-310000072331ndsn:SeniorNotesDue20232027Member2026-01-310000072331ndsn:SeniorNotesDue20232027Member2025-10-310000072331ndsn:SeniorNotesDue20232030Member2026-01-310000072331ndsn:SeniorNotesDue20232030Member2025-10-310000072331ndsn:Due2028Member2023-09-130000072331ndsn:Due2028Member2025-10-310000072331ndsn:Due2033Member2023-09-130000072331ndsn:Due2033Member2025-10-310000072331ndsn:Due2029Member2024-09-090000072331ndsn:Due2029Member2025-10-310000072331ndsn:RevolvingCreditAgreementDue2031Member2026-01-300000072331ndsn:TermLoanDue2026Member2023-06-060000072331ndsn:RevolvingCreditAgreementDue2028Member2023-06-060000072331us-gaap:RevolvingCreditFacilityMember2026-01-310000072331ndsn:SeniorNotesDue20232027Member2025-11-012026-01-310000072331ndsn:SeniorNotesDue20232030Member2025-11-012026-01-310000072331ndsn:SundaramNagarajanMember2025-11-012026-01-310000072331ndsn:SundaramNagarajanMember2026-01-310000072331ndsn:JosephP.KelleyMember2025-11-012026-01-310000072331ndsn:JosephP.KelleyMember2026-01-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended January 31, 2026

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from           to         

Commission file number   0-7977

____________________________________________________

NORDSON CORPORATION

(Exact name of registrant as specified in its charter)

___________________________________________________

Ohio

(State or other jurisdiction of incorporation or organization)

28601 Clemens Road

Westlake, Ohio

(Address of principal executive offices)

34-0590250

(I.R.S. Employer Identification No.)

44145

(Zip Code)

(440) 892-1580

(Registrant's Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s)

Name of Each Exchange On Which Registered

Common Shares, without par value

NDSN

Nasdaq Stock Market LLC

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).    Yes  x    No  o

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  x

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:  Common Shares, without par value as of February 18, 2026:  55,783,598

Table of Contents

PART I – FINANCIAL INFORMATION			3
ITEM 1.  FINANCIAL STATEMENTS (UNAUDITED)			3
Condensed Consolidated Statements of Income			3
Consolidated Statements of Comprehensive Income			3
Consolidated Balance Sheets			4
Consolidated Statements of Shareholders' Equity			5
Condensed Consolidated Statements of Cash Flows			6
Notes to Condensed Consolidated Financial Statements			7
ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS			19
Overview			19
Critical Accounting Policies and Estimates			19
Results of Operations			19
Financial Condition			21
ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK			22
ITEM 4.  CONTROLS AND PROCEDURES			22
PART II – OTHER INFORMATION			23
ITEM 1.  LEGAL PROCEEDINGS			23
ITEM 1A.  RISK FACTORS			23
ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS			23
ITEM 5. OTHER INFORMATION			24
ITEM 6.  EXHIBITS			24
SIGNATURE			25

Page 2

Table of Contents

Nordson Corporation

Part I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

Condensed Consolidated Statements of Income

						Three Months Ended
(In thousands, except for per share data)						January 31, 2026						January 31, 2025
Sales						$	669,461					$	615,420
Cost of sales						303,339						279,524
Selling and administrative expenses						199,717						194,949
Operating profit						166,405						140,947
Interest expense						(23,131)						(26,559)
Interest and investment income						390						941
Other income - net						20,837						1,526
Income before income taxes						164,501						116,855
Income tax expense						31,119						22,203
Net income						$	133,382					$	94,652
Average common shares						55,789						57,129
Incremental common shares attributable to equity compensation						338						357
Average common shares and common share equivalents						56,127						57,486
Basic earnings per share						$	2.39					$	1.66
Diluted earnings per share						$	2.38					$	1.65

See accompanying notes.

Consolidated Statements of Comprehensive Income

						Three Months Ended
(In thousands)						January 31, 2026						January 31, 2025
Net income						$	133,382					$	94,652
Components of other comprehensive income (loss), net of tax:
Foreign currency translation and related hedging adjustments						42,959						(51,679)
Pension and postretirement benefit plans						295						512
Total other comprehensive income						43,254						(51,167)
Total comprehensive income						$	176,636					$	43,485

See accompanying notes.

Page 3

Table of Contents

Nordson Corporation

Consolidated Balance Sheets

(In thousands)
Assets
Current assets:						January 31, 2026						October 31, 2025
Cash and cash equivalents						$	120,392					$	108,442
Receivables - net						571,583						587,843
Inventories - net						451,138						444,814
Prepaid expenses and other current assets						108,558						101,752
Total current assets						1,251,671						1,242,851
Goodwill						3,332,244						3,304,685
Intangible assets - net						671,456						681,587
Property, plant and equipment - net						521,508						516,914
Operating right of use lease assets						69,758						77,478
Deferred income taxes						11,320						11,246
Other assets						102,965						82,920
						$	5,960,922					$	5,917,681
Liabilities and shareholders' equity
Current liabilities:
Current maturities of long-term debt and notes payable						$	54,312					$	315,000
Accrued liabilities						182,964						229,095
Accounts payable						117,708						121,006
Customer advanced payments						47,783						44,009
Income taxes payable						35,060						25,856
Operating lease liability - current						16,238						17,402
Finance lease liability - current						5,984						5,892
Total current liabilities						460,049						758,260
Long-term debt						1,943,182						1,681,254
Deferred income taxes						194,321						192,186
Operating lease liability - noncurrent						56,747						64,451
Postretirement obligations						43,548						43,786
Pension obligations						44,903						43,205
Finance lease liability - noncurrent						8,210						8,359
Other long-term liabilities						97,856						82,609
Shareholders' equity:
Common shares						12,253						12,253
Capital in excess of stated value						762,137						740,789
Retained earnings						4,688,200						4,600,604
Accumulated other comprehensive loss						(57,203)						(100,457)
Common shares in treasury, at cost						(2,293,281)						(2,209,618)
Total shareholders' equity						3,112,106						3,043,571
						$	5,960,922					$	5,917,681

See accompanying notes.

Page 4

Table of Contents

Nordson Corporation

Consolidated Statements of Shareholders’ Equity

						Three Months Ended January 31, 2026
(In thousands, except for share and per share data)						Common Shares						Additional Paid-in Capital						Retained Earnings						Accumulated Other Comprehensive Income (Loss)						Common Shares in Treasury, at cost						TOTAL
November 1, 2025						$	12,253					$	740,789					$	4,600,604					$	(100,457)					$	(2,209,618)					$	3,043,571
Shares issued under company stock and employee benefit plans						—						16,457						—						—						2,338						18,795
Stock-based compensation						—						4,891						—						—						—						4,891
Purchase of treasury shares						—						—						—						—						(86,001)						(86,001)
Dividends declared ($0.82 per share)						—						—						(45,786)						—						—						(45,786)
Net income						—						—						133,382						—						—						133,382
Other comprehensive income						—						—						—						43,254						—						43,254
January 31, 2026						$	12,253					$	762,137					$	4,688,200					$	(57,203)					$	(2,293,281)					$	3,112,106

						Three Months Ended January 31, 2025
(In thousands, except for share and per share data)						Common Shares						Additional Paid-in Capital						Retained Earnings						Accumulated Other Comprehensive Income (Loss)						Common Shares in Treasury, at cost						TOTAL
November 1, 2024						$	12,253					$	714,091					$	4,295,199					$	(184,840)					$	(1,904,511)					$	2,932,192
Shares issued under company stock and employee benefit plans						—						349						—						—						652						1,001
Stock-based compensation						—						4,633						—						—						—						4,633
Purchase of treasury shares						—						—						—						—						(60,098)						(60,098)
Dividends declared ($0.78 per share)						—						—						(44,602)						—						—						(44,602)
Net income						—						—						94,652						—						—						94,652
Other comprehensive loss						—						—						—						(51,167)						—						(51,167)
January 31, 2025						$	12,253					$	719,073					$	4,345,249					$	(236,007)					$	(1,963,957)					$	2,876,611

See accompanying notes.

Page 5

Table of Contents

Nordson Corporation

Condensed Consolidated Statements of Cash Flows

(In thousands)						Three Months Ended
Cash flows from operating activities:						January 31, 2026						January 31, 2025
Net income						$	133,382					$	94,652
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization						36,585						37,031
Non-cash stock compensation						4,891						4,633
Deferred income taxes						5,620						(2,223)
Other non-cash (income) expense						(21,410)						584
(Gain) loss on sale of property, plant and equipment						(776)						166
Changes in operating assets and liabilities and other						(17,864)						24,279
Net cash provided by operating activities						140,428						159,122
Cash flows from investing activities:
Additions to property, plant and equipment						(17,513)						(21,399)
Proceeds from sale of property, plant and equipment						1,103						298
Other						(1,261)						6,825
Net cash used in investing activities						(17,671)						(14,276)
Cash flows from financing activities:
Proceeds from issuance of debt						267,360						1,655
Repayment of debt						(264,993)						(24,218)
Repayment of finance lease obligations						(1,616)						(1,320)
Issuance of common shares						18,795						1,001
Purchase of treasury shares						(86,001)						(60,098)
Dividends paid						(45,786)						(44,602)
Net cash used in financing activities						(112,241)						(127,582)
Effect of exchange rate changes on cash						1,434						(2,792)
Increase in cash and cash equivalents						11,950						14,472
Cash and cash equivalents at beginning of period						108,442						115,952
Cash and cash equivalents at end of period						$	120,392					$	130,424

See accompanying notes.

Page 6

Table of Contents

Nordson Corporation

Notes to Condensed Consolidated Financial Statements

January 31, 2026

NOTE REGARDING AMOUNTS AND FISCAL YEAR REFERENCES

In this Quarterly Report on Form 10-Q, all amounts related to United States dollars and foreign currency and to the number of Nordson Corporation’s common shares, except for per share earnings and dividend amounts, are expressed in thousands. Unless the context otherwise indicates, all references to “we” or the “Company” mean Nordson Corporation.

Unless otherwise noted, all references to years relate to our fiscal year ending October 31.

Significant accounting policies

Basis of presentation.  The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles in the United States ("U.S. GAAP") for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended January 31, 2026 are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the Consolidated Financial Statements and notes included in our Annual Report on Form 10-K for the year ended October 31, 2025.

Consolidation.  The Condensed Consolidated Financial Statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50% or less or in which we do not have control but have the ability to exercise significant influence are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation.  

Use of estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements. Actual amounts could differ from these estimates.

Revenue recognition. A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. For products in which control transfers upon delivery, revenue is deferred for undelivered items and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of January 31, 2026 and October 31, 2025 were not material.

For certain contracts related to the sale of customer-specific products, revenue is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled, and we are contractually entitled to payment for work performed to date plus a reasonable margin.  

As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material as of January 31, 2026 and October 31, 2025. Revenue recognized over time represented approximately less than ten percent of our overall consolidated revenues for the periods ended January 31, 2026 and October 31, 2025.

Revenue is measured as the amount of consideration we expect to be entitled to in exchange for transferring products or services. Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs, as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred, as the amortization period resulting from capitalizing the

Page 7

Table of Contents

Nordson Corporation

costs is one year or less. These costs are recorded within Selling and administrative expenses in our Condensed Consolidated Statements of Income.

We offer assurance-type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and is not material. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, and therefore, these items are typically regarded as inconsequential or not material.

We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to our Operating segments Note for details.

Earnings per share.  Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted shares and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options for 73 and 193 common shares were excluded from the calculation of diluted earnings per share for the three months ended January 31, 2026 and 2025, respectively, because their effect would have been anti-dilutive. Under the 2021 Stock Incentive and Award Plan, executive officers and selected other key employees receive common share awards based on corporate performance measures over three-year performance periods. Awards for which performance measures have not been met were excluded from the calculation of diluted earnings per share.

Recently issued accounting standards

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 requires enhanced disclosures about significant segment expenses and enhanced disclosures in interim periods. The guidance in ASU 2023-07 is to be applied retrospectively and is effective for annual reporting periods in fiscal years beginning after December 15, 2023 and interim reporting periods in fiscal years beginning after December 31, 2024, with early adoption permitted. The Company adopted the guidance of ASU 2023-07 during the fourth quarter of 2025. See Operating Segments Note.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 is intended to improve income tax disclosure requirements by requiring specific disclosure in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The guidance in ASU 2023-09 will be effective for annual reporting periods in fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact that the adoption of ASU 2023-09 will have on its consolidated financial statements and disclosures and anticipates adoption in fiscal 2026 in its Annual Report on Form 10-K for the year ending October 31, 2026.

In November 2024, the FASB issued ASU 2024-03, Income Statement (Topic 220): Reporting Comprehensive Income. ASU 2024-03 does not change or remove current expense presentation requirements within the Consolidated Statements of Income. However, the amendments require disclosure, on an annual and interim basis, disaggregated information about certain income statement expense line items within the notes to the consolidated financial statements. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact that the adoption of ASU 2024-03 will have on its consolidated financial statements and disclosures and anticipates adoption in fiscal 2028.

Acquisitions

Business acquisitions have been accounted for using the acquisition method, with the acquired assets and liabilities recorded at estimated fair value on the dates of acquisition. The cost in excess of the net assets of the business acquired is included in goodwill. Operating results since the respective dates of acquisitions are included in the Condensed Consolidated Statements of Income.

Receivables

Our primary allowance for credit losses is the allowance for doubtful accounts, which is principally determined based on aging of receivables. Receivables are exposed to credit risk based on the customers' ability to pay which is influenced by, among other factors, their financial liquidity. We perform ongoing customer credit evaluation to maintain sufficient allowances for potential credit losses. Our segments perform credit evaluation and monitoring to estimate and manage credit risk through the review of customer information, credit ratings, approval and monitoring of customer credit limits and assessment of market conditions. We may also require prepayments or bank guarantees from customers to mitigate credit risk. Our receivables are generally short-term

Page 8

Table of Contents

Nordson Corporation

in nature with a majority of receivables outstanding less than 90 days. Accounts receivable balances are written-off against the allowance if deemed uncollectible.

Accounts receivable are net of an allowance for credit losses of $6,504 and $7,408 on January 31, 2026 and October 31, 2025, respectively. Provision income was $589 for the three months ended January 31, 2026 compared to provision income of $382 for the three months ended January 31, 2025. The remaining change in the allowance for credit losses is principally related to the write-off of uncollectible accounts.

Inventories

Components of inventories were as follows:

						January 31, 2026						October 31, 2025
Finished goods						$	243,587					$	234,710
Raw materials and component parts						227,554						230,907
Work-in-process						61,504						57,306
						532,645						522,923
Obsolescence and other reserves						(81,507)						(78,109)
						$	451,138					$	444,814

Property, Plant and Equipment

Components of property, plant and equipment were as follows:

			January 31, 2026						October 31, 2025
Land			$	32,761					$	32,579
Land improvements			4,939						4,914
Buildings			363,125						360,038
Machinery and equipment			690,721						682,093
Enterprise management system			53,694						53,694
Construction-in-progress			40,298						29,522
Leased property under finance leases			28,656						27,680
			1,214,194						1,190,520
Accumulated depreciation			(692,686)						(673,606)
			$	521,508					$	516,914

Depreciation expense was $17,016 and $17,720 for the three months ended January 31, 2026 and 2025, respectively.

Goodwill and other intangible assets  

Our reporting units are the same as our reportable operating segments, Industrial Precision Solutions ("IPS"), Medical and Fluid Solutions ("MFS"), and the Advanced Technology Solutions ("ATS") segments. Changes in the carrying amount of goodwill for the three months ended January 31, 2026 by operating segment:

						IPS						MFS						ATS						Total
Balance at October 31, 2025						$	1,210,366					$	1,647,468					$	446,851					$	3,304,685
Currency effect						23,125						1,163						3,271						27,559
Balance at January 31, 2026						$	1,233,491					$	1,648,631					$	450,122					$	3,332,244

Page 9

Table of Contents

Nordson Corporation

Information regarding intangible assets subject to amortization:

						January 31, 2026
						Carrying  Amount						Accumulated Amortization						Net Book  Value
Customer relationships						$	910,541					$	405,243					$	505,298
Patent/technology costs						237,558						162,588						74,970
Trade name						170,403						79,215						91,188
Non-compete agreements						8,686						8,686						—
Other						921						921						—
Total						$	1,328,109					$	656,653					$	671,456
						October 31, 2025
						Carrying  Amount						Accumulated Amortization						Net Book  Value
Customer relationships						$	899,402					$	390,751					$	508,651
Patent/technology costs						235,255						155,865						79,390
Trade name						169,127						75,581						93,546
Non-compete agreements						8,596						8,596						—
Other						929						929						—
Total						$	1,313,309					$	631,722					$	681,587

Amortization expense for the three months ended January 31, 2026 and 2025 was $19,569 and $19,311, respectively.

Pension and other postretirement plans

The components of net periodic pension costs for the three months ended January 31, 2026 and 2025 were:

						U.S.												International
						2026						2025						2026						2025
Service cost						$	2,062					$	2,531					$	133					$	232
Interest cost						4,580						4,691						604						623
Expected return on plan assets						(6,645)						(6,609)						(547)						(638)
Amortization of prior service credit						—						—						(2)						(2)
Amortization of net actuarial (gain) loss						1,051						474						(86)						(67)
Total benefit cost						$	1,048					$	1,087					$	102					$	148

The components of other postretirement benefit costs, for plans in the United States, for the three months ended January 31, 2026 and 2025:

						2026						2025
Service cost						$	35					$	59
Interest cost						522						650
Amortization of net actuarial gain						(413)						(126)
Total benefit cost						$	144					$	583

The components of net periodic pension and other postretirement cost, other than service cost, are included in Other – net in our Condensed Consolidated Statements of Income.

Page 10

Table of Contents

Nordson Corporation

Income taxes

We record our interim provision for income taxes based on our estimated annual effective tax rate, as well as certain items discrete to the current period. The effective tax rate for the three months ended January 31, 2026 and 2025 was 18.9% and 19.0%, respectively. The effective tax rate for the three months ended January 31, 2026 was lower than the U.S. tax rate of 21% primarily due to the foreign-derived intangible income deduction.

One Big Beautiful Bill Act

On July 4, 2025, the One Big Beautiful Bill Act (the "OBBBA") was signed into law in the United States. The OBBBA includes significant tax law changes, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. While several provisions under the OBBBA begin to take effect during the Company’s fiscal year ended October 31, 2026, the OBBBA did not have a material impact on the Company’s consolidated financial statements in the three months ended January 31, 2026. The Company will continue to assess the impact of the OBBBA for the year ending October 31, 2026. The OBBBA is not expected to have a material impact on the effective tax rate.

Accumulated other comprehensive income (loss)

Changes in accumulated other comprehensive income (AOCI) consisted of:

						Cumulative translation and related hedging instruments						Pension and postretirement  benefit plan adjustments						Accumulated other  comprehensive income (loss)
Balance at October 31, 2025 (1)						$	(50,518)					$	(49,939)					$	(100,457)
Other comprehensive income before reclassification adjustments						36,775						(131)						36,644
Reclassifications from AOCI to Statement of Income (2)						—						550						550
Tax impact						6,184						(124)						6,060
Balance at January 31, 2026 (1)						$	(7,559)					$	(49,644)					$	(57,203)

(1) Amounts net of tax.

(2) Included in the computation of net periodic cost (benefit) which is included in Other - net in our Consolidated Statements of Income. See Pension and other postretirement plans Note.

Warranties

We offer warranties to our customers depending on the specific product and terms of the customer purchase agreement. A typical warranty program requires that we repair or replace defective products within a specified time period (generally one year) measured from the date of delivery or first use. We record an estimate for future warranty-related costs based on actual historical return rates. Based on analysis of return rates and other factors, the adequacy of our warranty provisions is adjusted as necessary. The liability for warranty costs is included in Accrued liabilities in the Consolidated Balance Sheets.

Following is a reconciliation of the product warranty liability for the three months ended January 31, 2026 and 2025:

						2026						2025
Beginning balance at October 31						$	13,900					$	13,538
Accruals for warranties						3,022						1,596
Warranty payments						(2,854)						(2,856)
Currency adjustments						233						(351)
Ending balance						$	14,301					$	11,927

Page 11

Table of Contents

Nordson Corporation

Operating segments

We conduct business in three primary operating segments: 

Industrial Precision Solutions: This segment focuses on delivering proprietary dispensing and processing technology, both standard and highly customized equipment, to diverse end markets. Product lines commonly reduce material consumption, increase line efficiency through precision dispensing and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, sealants and other materials. This segment primarily serves the industrial, agricultural, consumer durables and non-durables markets.

Medical and Fluid Solutions: This segment includes the Company’s fluid management solutions for medical, high-tech industrial and other diverse end markets. Related plastic tubing, balloons, catheters, syringes, cartridges, tips and fluid connection components are used to dispense or control fluids within customers’ medical devices or products, as well as production processes.

Advanced Technology Solutions: This segment focuses on products serving electronics and consumer non-durable end markets. Advanced Technology Solutions products integrate our proprietary product technologies found in progressive stages of an electronics customer’s production and measurement and control processes, such as surface treatment, precisely controlled dispensing of material and test and inspection to ensure quality and reliability. Applications include, but are not limited to, semiconductors, printed circuit boards, electronic components and automotive electronics, in-line measurement sensors, gauges and analyzers.

The composition of segments and measure of segment profitability is consistent with that used by our chief operating decision maker ("CODM"), our President and Chief Executive Officer. The primary measure used by our CODM for purposes of making decisions about allocating resources to the segments and assessing performance is segment EBITDA, which equals sales less adjusted cost of sales and adjusted selling and administrative expenses plus depreciation. Cost of sales and selling and administrative expenses are adjusted for certain special items such as non-recurring cost reduction activities and acquisition related costs, including intangible asset amortization. The CODM uses segment EBITDA in the annual budgeting and forecasting processes and regularly evaluates segment EBITDA results versus budget, forecast and prior year when making allocation of capital, financial and employee resource decisions.

The accounting policies of the segments are the same as those described in our Significant accounting policies Note. There are no intersegment sales. Certain expenses are maintained at the corporate level and not allocated to the segments. These expenses include executive compensation, charitable donations, corporate facilities, and other items that are of a corporate or functional governance nature. Interest expense-net and other income/expense-net are excluded from the measure of segment profitability reviewed by our CODM and are not presented by operating segment.

Page 12

Table of Contents

Nordson Corporation

The following table presents information about our reportable segments as further reconciled to consolidated GAAP financial results:

						Three Months Ended
						January 31, 2026						January 31, 2025
Sales
Industrial Precision Solutions						$	326,861					$	300,448
Medical and Fluid Solutions						193,183						193,609
Advanced Technology Solutions						149,417						121,363
Total segment sales						669,461						615,420
Adjusted cost of sales
Industrial Precision Solutions						(134,755)						(113,147)
Medical and Fluid Solutions						(96,555)						(103,369)
Advanced Technology Solutions						(72,029)						(54,859)
Total segment adjusted cost of sales						(303,339)						(271,375)
Adjusted selling and administrative expenses
Industrial Precision Solutions						(87,750)						(80,169)
Medical and Fluid Solutions						(34,261)						(34,612)
Advanced Technology Solutions						(46,375)						(45,317)
Total segment adjusted selling and administrative expenses						(168,386)						(160,098)
Depreciation
Industrial Precision Solutions						5,955						5,644
Medical and Fluid Solutions						7,840						8,704
Advanced Technology Solutions						1,587						1,584
Total segment depreciation						15,382						15,932
EBITDA
Industrial Precision Solutions						110,311						112,776
Medical and Fluid Solutions						70,206						64,332
Advanced Technology Solutions						32,600						22,771
Total segment EBITDA						213,117						199,879
Inventory step-up amortization						—						(3,135)
Acquisition related costs						—						(1,030)
Severance and other						—						(5,961)
Depreciation and amortization						(36,585)						(37,030)
Corporate expenses						(10,127)						(11,776)
Interest expense						(23,131)						(26,559)
Interest and investment income						390						941
Other - net						20,837						1,526
Income before taxes						$	164,501					$	116,855

Page 13

Table of Contents

Nordson Corporation

The following table presents additional information about our reportable segments for the three months ended or period ended:

			Industrial Precision Solutions						Medical and Fluid Solutions						Advanced Technology Solutions						Corporate						Total
January 31, 2026
Amortization of intangibles			$	7,520					$	9,671					$	2,378					$	—					$	19,569
Identifiable assets (1)			1,881,578						2,187,997						747,941						1,143,406						5,960,922
Property, plant and equipment expenditures			3,265						5,325						8,717						206						17,513
January 31, 2025
Amortization of intangibles			$	6,810					$	9,437					$	3,064					$	—					$	19,311
Identifiable assets (1)			1,737,555						2,240,225						734,046						1,159,700						5,871,526
Property, plant and equipment expenditures			5,070						9,330						2,124						4,875						21,399

(1) Operating segment identifiable assets include notes and accounts receivable net of allowance for doubtful accounts, inventories net of reserves, property, plant and equipment net of accumulated depreciation and goodwill. Corporate assets are principally cash and cash equivalents, deferred income taxes, leases, headquarter facilities and intangible assets.

We had significant net sales, measured based on their geographic destination, and long-lived assets in the following geographic areas:

			January 31, 2026						January 31, 2025
Net external sales for three months ended
Americas			$	261,930					$	267,836
Europe			182,461						167,762
Asia Pacific			225,070						179,822
Total net external sales			$	669,461					$	615,420
Long-lived assets
Americas			$	421,462					$	465,600
Europe			108,566						103,813
Asia Pacific			61,238						56,849
Total long-lived assets			$	591,266					$	626,262

Net external sales in the United States were $198,523 for the three months ended January 31, 2026 and $208,820 for the three months ended January 31, 2025. Long-lived assets include property, plant and equipment - net and operating right of use lease assets. Long-lived assets in the U.S. were $412,713 and $450,029 as of January 31, 2026 and 2025, respectively.

Investments

The Company holds minority interests in certain companies that do not have readily determinable fair values. For each qualifying investment, the Company elects the measurement alternative under ASC 321, initially recognizing the investment at cost and subsequently adjusting the carrying amount for (i) impairment, and (ii) observable price changes in orderly transactions for an identical or similar investment of the same issuer. Investments subject to the measurement alternative are classified in Other assets on the Consolidated Balance Sheets and were $7,335 and $13,996, at January 31, 2026 and October 31, 2025, respectively. Adjustments (upward or downward) and impairment losses, if any, are recognized in earnings within Other-net and were not material for fiscal 2026 and 2025. If a readily determinable fair value for the investments subsequently becomes available, we will be required to record the investment at fair value with any unrealized gains or losses being recognized in earnings each period.

In December 2025, one of the Company's minority interest investments was publicly listed on a foreign stock exchange. The fair value of this investment is included in Other assets on the Consolidated Balance Sheets and was $29,238 as of January 31, 2026. The unrealized gain of $22,238 for the three months ended January 31, 2026 was included in Other-net in the Condensed Consolidated Statements of Income. Nordson is contractually restricted from selling any shares in this investment until December 2028 and there are no circumstances that could cause this restriction to lapse earlier.

Page 14

Table of Contents

Nordson Corporation

Fair value measurements

The inputs to the valuation techniques used to measure fair value are classified into the following categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis:

January 31, 2026						Total						Level 1						Level 2						Level 3
Net derivative contracts (1)						$	(59,465)					$	—					$	(59,465)					$	—
Deferred compensation plans (2)						(13,356)						—						(13,356)						—
Minority interest investment (3)						29,238						29,238						—						—

October 31, 2025						Total						Level 1						Level 2						Level 3
Net derivative contracts (1)						$	(55,367)					$	—					$	(55,367)					$	—
Deferred compensation plans (2)						(11,885)						—						(11,885)						—

(1) Derivative contracts are valued using an industry standard market approach, in which prices and other relevant information is generated by market transactions involving identical or comparable assets or liabilities. Refer to Derivative financial instruments note for balance sheet classification of derivatives.

(2) Executive officers and other highly compensated employees may defer up to 100% of their salary and annual cash incentive compensation and for executive officers, up to 90% of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.

(3) Refer to Investments note for additional details.

The carrying amounts and fair values of financial instruments, other than cash and cash equivalents, receivables and accounts payable are shown in the table below. The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments.

						January 31, 2026												October 31, 2025
						Carrying Amount						Fair Value						Carrying Amount						Fair Value
Long-term debt (including current portion)						$	1,984,051					$	2,041,426					$	1,996,254					$	2,038,869

Long-term debt is valued by discounting future cash flows at currently available rates for borrowing arrangements with similar terms and conditions, which are considered to be Level 2 inputs under the fair value hierarchy. The carrying amount of long-term debt is shown net of unamortized debt issuance costs and bond discounts as described in the Long-term debt Note.

Derivative financial instruments  

The Company uses derivative instruments to manage foreign currency and interest rate risk as detailed below. The Company does not enter into derivative instruments for trading purposes.

Foreign Currency Forward Contracts

We operate internationally and enter into transactions denominated in foreign currencies. Consequently, we are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled. We regularly use foreign currency forward contracts to reduce our risks related to most of these transactions. These contracts usually have maturities of 90 days or less and generally require us to exchange foreign currencies for U.S. dollars at maturity, at rates stated in the contracts. These contracts are not designated as hedging instruments under U.S. GAAP. The settlement of these contracts is recorded in operating activities on the Consolidated Statement of Cash Flows.

We are exposed to credit-related losses in the event of nonperformance by counterparties to financial instruments. These financial instruments include cash deposits and foreign currency forward contracts. We periodically monitor the credit ratings of these counterparties in order to minimize our exposure. Our customers represent a wide variety of industries and geographic regions. As of January 31, 2026 and 2025, there were no significant concentrations of credit risk.

Page 15

Table of Contents

Nordson Corporation

Net Investment Hedges

Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We may utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries.

The Company is a party to various cross currency swaps between the U.S. dollar and Euro, Japanese Yen, Taiwan dollar, Singapore dollar and Chinese Yuan, which were designated as hedges of our net investments in certain foreign subsidiaries to mitigate the foreign exchange risk associated with certain investments in these subsidiaries. Any increases or decreases related to the remeasurement of the effective portion of the hedges are recorded in the currency translation component of Accumulated other comprehensive income (loss) within Shareholders' Equity in the Consolidated Balance Sheets until the sale or substantial liquidation of the underlying investments. The settlement of these hedges is recorded in investing activities on the Consolidated Statement of Cash Flows. The interest component is recorded in operating activities on the Consolidated Statement of Cash Flows.

Fair Value Hedges of Interest Rate Risk

The Company is exposed to changes in the fair value of certain of its fixed-rate liabilities due to changes in benchmark interest rates. The Company uses interest rate swaps to manage its exposure to changes in fair value on these instruments attributable to changes in the designated benchmark interest rate, the Secured Overnight Financing Rate ("SOFR"), with the objective of minimizing the cost of borrowed funds. The Company's interest rate swaps involve the receipt of fixed-rate amounts from a counterparty in exchange for the Company making variable-rate payments without the exchange of the underlying notional amount.

The Company's interest rate swaps are designated and qualify as fair value hedges. As a result, the interest rate swaps are measured at fair value and the carrying value of the hedged debt is adjusted for the change in value related to the exposure being hedged, with both adjustments offset to earnings. Accordingly, the earnings effect of an increase in the fair value of the interest rate swaps will be substantially offset by the earnings effect of the increase in the carrying value of the hedged debt.

The following table provides information regarding the Company's outstanding interest rate derivatives that were used to hedge changes in fair value attributable to interest rate risk:

						Interest rate swaps - notional amount						Cumulative adjustment to long-term debt from application of hedge accounting						Carrying value of hedged debt
Interest rate swaps						$	300,000					$	9,131					$	309,131

The following table provides information regarding the balance sheet and income statement impacts of the Company's derivatives:

January 31, 2026						Notional Amount $						Prepaid and other current assets						Other assets						Accrued liabilities						Other long-term liabilities			Type of hedge
Derivatives designated as hedges:
Cross-currency swap						$	928,098					$	3,839					$	—					$	10,041					$	75,583		Net investment
Interest rate swap						300,000						1,396						7,735						—						—			Fair value
Derivatives not designated as hedges:
Foreign currency forward contracts						1,036,125						14,704						—						1,515						—
Total												$	19,939					$	7,735					$	11,556					$	75,583

Page 16

Table of Contents

Nordson Corporation

October 31, 2025						Notional Amount $						Prepaid and other current assets						Other assets						Accrued liabilities						Other long-term liabilities			Type of hedge
Derivatives designated as hedges:
Cross-currency swap						$	863,904					$	5,937		$	73		$	—		$	10,675		$	676					$	61,725		Net investment
Interest rate swap						300,000						1,133						10,353						—						—			Fair value
Derivatives not designated as hedges:
Foreign currency forward contracts						1,137,956						4,961						—						15,350						—
Total												$	12,031					$	10,353					$	16,026					$	61,725

						Gain (Loss) Recognized												Location
						January 31, 2026						January 31, 2025
Derivatives designated as hedges:
Interest rate swaps						$	(2,355)					$	2,986					Interest expense
Hedged item						$	2,355					$	(2,986)					Interest expense
Cross-currency swap - interest component						$	3,628					$	3,737					Interest expense
Cross-currency swap - effective portion						$	(26,560)					$	37,038					Cumulative translation
Derivatives not designated as hedges
Foreign currency forward contracts						$	23,579					$	(4,363)					Other-net
Foreign currency balance sheet remeasurement						$	(25,873)					$	4,694					Other-net

Long-term debt

A summary of long-term debt is as follows:

						January 31, 2026						October 31, 2025
Notes Payable						$	4,312					$	—
Revolving credit agreement, due 2031						400,000						—
Revolving credit agreement, due 2028						—						135,000
Term loan due 2026						—						265,000
Senior notes, due 2026-2027						20,000						20,000
Senior notes, due 2026-2030						130,000						130,000
5.600% Notes due 2028						350,000						350,000
5.800% Notes due 2033						500,000						500,000
4.500% Notes due 2029						600,000						600,000
						2,004,312						2,000,000
Less current maturities						54,312						315,000
Less unamortized debt issuance costs						13,978						13,167
Less bond discounts						1,971						2,065
Plus impact of interest rate swaps						9,131						11,486
Long-term maturities						$	1,943,182					$	1,681,254

Page 17

Table of Contents

Nordson Corporation

Revolving credit agreement — In January 2026, we entered into a $1,200,000 senior unsecured multicurrency revolving credit facility with a group of banks, maturing in January 2031 (the “Revolving Credit Agreement”), which amended and restated the Company’s previous unsecured senior credit agreement, dated June 6, 2023, that included a term loan facility in the aggregate principal amount of $300,000, maturing in June 2026, and a multicurrency revolving credit facility in the aggregate principal amount of $922,500, maturing in June 2028. The Company borrowed and had $400,000 outstanding on the Revolving Credit Agreement as of January 31, 2026. The Revolving Credit Agreement permits borrowing in U.S. Dollars, Euros, Sterling, Swiss Francs, Singapore Dollars, Japanese Yen, and each other currency approved by the Revolving Agent and the Revolving Credit Banks (each as defined in the Revolving Credit Agreement). Loans under the Revolving Credit Agreement bear interest at the sum of (i) either a base rate or, depending on the currency, a SOFR rate, EURIBOR rate, TIBOR rate, SORA rate, SONIA rate or SARON rate (each as defined in the Revolving Credit Agreement) plus (ii) an applicable margin. The applicable margin is based on either the Company’s Leverage Ratio (as defined in the Revolving Credit Agreement) or then current Debt Rating (as defined in the Revolving Credit Agreement). The weighted-average interest rate at January 31, 2026 was 4.69%.

Senior notes, due 2026-2027 — These unsecured fixed-rate notes entered into in 2015 with a group of insurance companies have a remaining weighted-average life of 0.99 years. The weighted-average interest rate at January 31, 2026 was 3.19%.

Senior notes, due 2026-2030 — These unsecured fixed-rate notes entered into in 2018 with a group of insurance companies have a remaining weighted-average life of 2.39 years. The weighted-average interest rate at January 31, 2026 was 4.08%.  

5.600% Notes due 2028 and 5.800% Notes due 2033 — In September 2023, we completed an underwritten public offering of $350,000 aggregate principal amount of 5.600% Notes due 2028 and $500,000 aggregate principal amount of 5.800% Notes due 2033.

4.500% Notes due 2029 — In September 2024, we completed an underwritten public offering of $600,000 aggregate principal amount of 4.500% Notes due 2029.

We were in compliance with all covenants at January 31, 2026, and the amount we could borrow would not have been limited by any debt covenants.

Contingencies

We are involved in pending or potential litigation regarding environmental, product liability, patent, contract, employee and other matters arising from the normal course of business. After consultation with legal counsel, we do not believe that losses in excess of the amounts we have accrued would have a material adverse effect on our financial condition, quarterly or annual operating results or cash flows.

Page 18

Table of Contents

Nordson Corporation

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following is management's discussion and analysis of certain significant factors affecting our financial condition and results of operations for the periods included in the accompanying condensed consolidated financial statements. Throughout this Quarterly Report on Form 10-Q, components may not sum to totals due to rounding.

Overview

Nordson is an innovative precision technology company that leverages a scalable growth framework expected to deliver top tier growth with leading margins and returns. We engineer, manufacture and market differentiated products and systems used for precision dispensing, applying and controlling of adhesives, coatings, polymers, sealants, biomaterials, and other fluids, to test and inspect for quality, and to treat and cure surfaces and various medical products such as: catheters, cannulas, medical balloons and medical tubing. These products are supported with extensive application expertise and direct global sales and service. We serve a wide variety of consumer non-durable, consumer durable and technology end markets including packaging, electronics, medical, appliances, energy, transportation, precision agriculture, building and construction, and general product assembly and finishing.

Our strategy for long-term growth is based on solving customers’ needs globally. We were incorporated in the State of Ohio in 1954 and are headquartered in Westlake, Ohio. Our products are marketed through a network of direct operations in more than 35 countries.

As of January 31, 2026, we had approximately 8,200 employees worldwide. We have principal manufacturing operations and sources of supply in the United States, the People’s Republic of China, Germany, Ireland, India, Israel, Italy, Mexico, the Netherlands and the United Kingdom.

Critical Accounting Policies and Estimates

A comprehensive discussion of the Company’s critical accounting policies and management estimates and significant accounting policies followed in the preparation of the financial statements is included in Item 7 of our Annual Report on Form 10-K for the year ended October 31, 2025 (the "2025 Form 10-K"). There have been no significant changes in critical accounting policies, management estimates or accounting policies followed since the year ended October 31, 2025.

Results of Operations

Below is a detailed comparison of our results of operations for the three months ended January 31, 2026 and January 31, 2025.

As used throughout this Quarterly Report on Form 10-Q, geographic regions include the Americas (United States, Canada, Mexico and Central and South America), Asia Pacific and Europe.

Consolidated Financial Results

Consolidated financial results for the three months ended January 31, 2026 and January 31, 2025 were as follows:

						Three Months Ended
(In thousands except for per-share amounts)						January 31, 2026						January 31, 2025						Change
Sales						$	669,461					$	615,420					8.8		%
Cost of sales						303,339						279,524						8.5		%
Gross margin						366,122						335,896						9.0		%
Gross margin %						54.7		%				54.6		%				0.1		%
Selling and administrative expenses						199,717						194,949						2.4		%
Operating profit						166,405						140,947						18.1		%
Interest expense - net						(22,741)						(25,618)						(11.2)		%
Other income - net						20,837						1,526						1265.5		%
Income before income taxes						164,501						116,855						40.8		%
Income tax expense						31,119						22,203						40.2		%
Net income						$	133,382					$	94,652					40.9		%

Page 19

Table of Contents

Nordson Corporation

Net Sales

Net sales for the IPS, MFS and ATS segments were as follows:

			Three Months Ended															Variance - Increase (Decrease)
			Jan 31, 2026			% of Total			Jan 31, 2025			% of Total						Organic						Acquisitions / Divestitures						Currency						Total
IPS			$	326,861		48.8%			$	300,448		48.8%						3.2		%				—		%				5.6		%				8.8		%
MFS			193,183			28.9%			193,609			31.5%						2.7		%				(4.3)		%				1.4		%				(0.2)		%
ATS			149,417			22.3%			121,363			19.7%						20.7		%				—		%				2.4		%				23.1		%
Total			$	669,461					$	615,420								6.5		%				(1.4)		%				3.7		%				8.8		%

The IPS organic sales increase of 3.2 percent was driven by balanced growth across most product lines, with particular strength in Asia Pacific markets. MFS organic sales increased 2.7 percent driven by growth in fluid solutions product lines. The ATS organic sales increase of 20.7 percent was driven by ongoing growth in electronics dispense and recovering demand for x-ray systems.

Net Sales by region were as follows:

			Three Months Ended															Variance - Increase (Decrease)
			Jan 31, 2026			% of Total			Jan 31, 2025			% of Total						Organic						Acquisitions / Divestitures						Currency						Total
Americas			$	261,930		39.1%			$	267,836		43.5%						(0.4)		%				(2.9)		%				1.1		%				(2.2)		%
Europe			182,461			27.3%			167,762			27.3%						(0.3)		%				(0.2)		%				9.3		%				8.8		%
Asia Pacific			225,070			33.6%			179,822			29.2%						23.2		%				—		%				2.0		%				25.2		%
Total			$	669,461					$	615,420								6.5		%				(1.4)		%				3.7		%				8.8		%

Gross profit and Selling and administrative expenses

Gross margins were 54.7 percent and 54.6 percent for the three months ended January 31, 2026 and January 31, 2025, respectively. Selling and administrative expenses increased in support of higher sales but declined as a percentage of sales.

Profit

Segment EBITDA for the IPS, MFS and ATS segments and a reconciliation to consolidated operating profit were as follows for the three months ended January 31, 2026 and January 31, 2025, respectively:

						Three Months Ended
						Jan 31, 2026						% of Sales						Jan 31, 2025						% of Sales						% of Sales Change
Industrial precision solutions						$	110,311					33.7%						$	112,776					37.5%						(3.8)%
Medical and fluid solutions						70,206						36.3%						64,332						33.2%						3.1%
Advanced technology solutions						32,600						21.8%						22,771						18.8%						3.0%
Total segment EBITDA						213,117						31.8%						199,879						32.5%						(0.7)%
Inventory step-up amortization						—												(3,135)
Acquisition costs						—												(1,030)
Severance and other						—												(5,961)
Depreciation and amortization						(36,585)												(37,030)
Corporate expenses						(10,127)												(11,776)
Operating profit						$	166,405											$	140,947

Segment EBITDA for IPS decreased 380 basis points despite higher sales due to unfavorable product and geographic mix. Segment EBITDA for MFS increased 310 basis points due to favorable mix from divestiture of the contract manufacturing business and strong incremental performance on organic sales growth. Segment EBITDA for ATS increased 300 basis points driven by robust sales growth and controlled selling and administrative expenses.

Consolidated operating profit increased in 2026 compared to 2025 due to the overall increase in segment EBITDA and lower corporate expenses as well as the absence of severance, acquisition and related inventory step-up amortization costs in 2026.

Page 20

Table of Contents

Nordson Corporation

Interest expense and Other expenses

Interest expense for the three months ended January 31, 2026 was $23,131, compared to $26,559 in the comparable period of 2025. The decrease, compared to the prior year period, was primarily due to lower average debt levels. Other income for the three months ended January 31, 2026 was $20,837 compared to $1,526 in the comparable period of 2025. Included in Other income for the three months ended January 31, 2026 was an unrealized gains on minority investment of $22,238, pension and postretirement income of $936 and $2,294 of foreign currency losses. Other income for the three months ended January 31, 2025 included pension and postretirement income of $1,015 and $331 in foreign currency gains.

Income Tax Expense

Income tax expense was $31,119, or 18.9% of pre-tax income, for the three months ended January 31, 2026, as compared to $22,203, or 19.0% of pre-tax income for the three months ended January 31, 2025.

Net Income

Net income was $133,382, or $2.38 per diluted share, for the three months ended January 31, 2026, compared to net income of $94,652, or $1.65 per diluted share, in the same period of 2025. This represented a 40.9 percent increase in net income and a 44.2 percent increase in diluted earnings per share. The increase of $0.73 per diluted share was driven by higher operating profit, lower interest expense, higher other income from the unrealized gain on minority investment and the benefit of share repurchases.

Financial Condition

Liquidity and Capital Resources

Cash and cash equivalents increased $11,950 during the three months ended January 31, 2026. Approximately 74 percent of our consolidated cash and cash equivalents were held at various foreign subsidiaries as of January 31, 2026.

A comparison of cash flow changes for the three months ended January 31, 2026 to the three months ended January 31, 2025 is as follows:

			Three Months Ended
			January 31, 2026						January 31, 2025						Increase (Decrease)
Net Income and non-cash items			$	158,292					$	134,843					$	23,449
Changes in operating assets and liabilities			(17,864)						24,279						(42,143)
Net cash provided by operating activities			140,428						159,122						(18,694)
Additions to property, plant and equipment			(17,513)						(21,399)						3,886
Other - net			(158)						7,123						(7,281)
Net cash used in investing activities			(17,671)						(14,276)						(3,395)
Net (repayment) issuance of long-term debt - net			2,367						(22,563)						24,930
Repayment of finance lease obligations			(1,616)						(1,320)						(296)
Dividends paid			(45,786)						(44,602)						(1,184)
Issuance of common shares			18,795						1,001						17,794
Purchase of treasury shares			(86,001)						(60,098)						(25,903)
Net cash used in financing activities			$	(112,241)					$	(127,582)					$	15,341

The decrease in working capital was principally driven by a decrease in cash provided by accounts receivable collections. During three months ended January 31, 2026, the Company was able to utilize its strong cashflow generation to repurchase $86 million in common shares, pay $46 million in dividends, and fund capital projects to drive organic growth.

We have a $1,200,000 unsecured multi-currency credit facility with a group of banks, maturing in January 2031. At January 31, 2026, we had $400,000 outstanding on the revolving credit facility.

Our operating performance, balance sheet position and financial ratios for the three months ended January 31, 2026 remained strong. We are in compliance with all covenants in the agreements governing our debt as of January 31, 2026. The Company is well-positioned to manage liquidity needs that arise from working capital requirements, capital expenditures, contributions related to pension and postretirement obligations, principal and interest payments on our outstanding debt, dividends, and share repurchases. Our primary sources of capital to meet these needs, as well as other opportunistic investments, are a combination of cash on hand, which was $120,392 as of January 31, 2026, cash provided by operations, which was $140,428 for the three months

Page 21

Table of Contents

Nordson Corporation

ended January 31, 2026, and available borrowings under our loan agreements and unused bank lines of credit, which totaled $945,420 as of January 31, 2026. Cash from operations, which when combined with our available borrowing capacity and ready access to capital markets, is expected to be more than adequate to fund our liquidity needs over the twelve months and the foreseeable future thereafter. The Company believes it has the ability to generate and obtain adequate amounts of cash to meet its short-term and long-term needs for cash. However, the impact of changes in trade policies, tariffs, and other import/export regulations of the United States and other nations could negatively impact our cash flow from operations and liquidity in future periods.

Safe Harbor Statements Under the Private Securities Litigation Reform Act of 1995

This Quarterly Report on Form 10-Q, particularly “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements within the meaning of the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements relate to, among other things, income, earnings, cash flows, changes in operations, operating improvements, businesses in which we operate and the United States and global economies. Statements in this annual report that are not historical are hereby identified as “forward-looking statements” and may be indicated by words or phrases such as “anticipates,” “supports,” “plans,” “projects,” “expects,” “believes,” “should,” “would,” “could,” “hope,” “forecast,” “management is of the opinion,” use of the future tense and similar words or phrases. These forward-looking statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic and political conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions and the Company’s ability to complete and successfully integrate acquisitions; the Company’s ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan; the effects of changes in U.S. trade policy and trade agreements, including changes in tariffs by the United States or other nations; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, including the conflicts in Europe and the Middle East, acts of terror, natural disasters and pandemics.

In light of these risks and uncertainties, actual events and results may vary significantly from those included in or contemplated or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Factors that could cause our actual results to differ materially from the expected results are discussed in Part I, Item 1A, Risk Factors in our 2025 Form 10-K and Part II, Item 1A, Risk Factors in the Quarterly Report on Form 10-Q.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Information regarding our financial instruments that are sensitive to changes in interest rates and foreign currency exchange rates was disclosed under Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” in our 2025 Form 10-K. The information disclosed has not changed materially in the interim period since then.

ITEM 4. CONTROLS AND PROCEDURES

Our management with the participation of the principal executive officer (president and chief executive officer) and principal financial officer (executive vice president and chief financial officer) has reviewed and evaluated our disclosure controls and procedures (as defined in the Exchange Act Rule 13a-15(e)) as of January 31, 2026. Based on that evaluation, our management, including the principal executive and financial officers, has concluded that our disclosure controls and procedures were effective as of January 31, 2026 in ensuring that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and is accumulated and communicated to management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting that occurred during the three months ended January 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Page 22

Table of Contents

Nordson Corporation

Part II – OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

See our Contingencies Note to the condensed consolidated financial statements for a discussion of our contingencies and legal matters.

ITEM 1A.    RISK FACTORS

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors disclosed in “Item 1A. Risk Factors” of our 2025 Form 10-K. There have been no material changes to the risk factors described in the 2025 Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table summarizes common shares repurchased by the Company during the three months ended January 31, 2026:

(In whole shares)						Total Number of Shares Repurchased (1)						Average Price Paid per Share						Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs (2)						Maximum Value of Shares that May Yet Be Purchased Under the Plans or Programs (2)
November 1, 2025 to November 30, 2025						115,699						$	232.49					115,653						$	697,345
December 1, 2025 to December 31, 2025						147,020						$	238.61					138,204						$	664,348
January 1, 2026 to January 31, 2026						87,883						$	258.95					87,089						$	641,802
Total						350,602						$	241.69					340,946						$	641,802

(1) Includes shares tendered for taxes related to stock option exercises and vesting of restricted stock.

(2) On August 20, 2025, the Company announced that its board of directors authorized the repurchase of up to an additional $500,000 of the Company's common shares. As of January 31, 2026, approximately $641,802 remained available for share repurchases under existing share repurchase authorizations. Uses for repurchased shares include the funding of benefit programs including stock options and restricted stock. Shares purchased are treated as treasury shares until used for such purposes. The repurchase program will be funded using cash from operations and proceeds from borrowings under our credit facilities. The repurchase program does not have an expiration date.

Page 23

                                          Table of Contents

Nordson Corporation

ITEM 5. OTHER INFORMATION

During the quarter ended January 31, 2026, no director or officer (as defined in Rule 16a-1(f) promulgated under the Exchange Act) of the Company adopted or terminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, except as described in the table below:

Trading Arrangement

Action

Action Date

Rule 10b5-11

Non-Rule 10b5-12

Total Shares to be Sold

Expiration Date

Sundaram Nagarajan Chief Executive Officer

Terminated3

1/12/2026

x

Up to 41,8004 shares

7/10/2026

Sundaram Nagarajan Chief Executive Officer

Adopted

1/12/2026

x

Up to 41,8005 shares

12/31/2026

Joseph P. Kelley Executive Vice President

Adopted

1/16/2026

x

Up to 2,310 shares

1/15/2027

1 Intended to satisfy the affirmative defense of Rule 10b5-1(c)

2 Not intended to satisfy the affirmative defense of Rule 10b5-1(c)

3 The 10b5-1 Plan originally adopted by Mr. Nagarajan on April 3, 2025, was terminated in connection with the adoption of a new Rule 10b5-1 Plan on January 12, 2026.

4 The Company’s prior disclosure in its Quarterly Report on Form 10‑Q for the quarterly period ended April 30, 2025 incorrectly stated that terminated Rule 10b5-1 Plan covered 40,000 shares. The correct number of shares covered under the terminated Rule 10b5-1 Plan was 41,800 shares.

5 Mr. Nagarajan's Rule 10b5-1 Plan provides for the potential sale of up to 41,800 shares of the Company’s common stock, all of which Mr. Nagarajan may acquire upon the exercise of outstanding stock options.

ITEM 6. EXHIBITS

10.1			Amended and Restated Credit Agreement, dated as of January 30, 2026, by and among Nordson Corporation, as Borrower, Nordson Engineering GmbH, as German Borrower, Wells Fargo Bank, National Association, as Administrative Agent, and various financial institutions named therein as lenders (incorporated herein by reference to Exhibit 10.1 to Registrant's Current Report on Form 8-K dated February 2, 2026).
31.1			Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 by the Chief Executive Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2			Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 by the Chief Financial Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1			Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
32.2			Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
101			The following financial information from Nordson Corporation’s Quarterly Report on Form 10-Q for the three months ended January 31, 2026 formatted in inline Extensible Business Reporting Language (iXBRL): (i) the Condensed Consolidated Statements of Income for the three months ended January 31, 2026 and 2025, (ii) the Consolidated Statements of Comprehensive Income for the three months ended January 31, 2026 and 2025, (iii) the Consolidated Balance Sheets at January 31, 2026 and October 31, 2025, (iv) the Consolidated Statements of Shareholders’ Equity for the three months ended January 31, 2026 and 2025, (v) the Condensed Consolidated Statements of Cash Flows for the three months ended January 31, 2026 and 2025, and (vi) the Notes to Condensed Consolidated Financial Statements.
104			The cover page from Nordson Corporation’s Quarterly Report on Form 10-Q for the quarter ended January 31, 2026, formatted in inline Extensible Business Reporting Language (iXBRL) (included in Exhibit 101).

Page 24

Table of Contents

Nordson Corporation

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:  February 19, 2026			Nordson Corporation
			/s/ Joseph Rutledge
			Joseph Rutledge
			Chief Accounting Officer

Page 25